Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Colan Totte CoTSE:7792 +0.34%90 ROA % is 19.34% as of Mar. 2026, which is 35% above its 10-year median of 14.36. GuruFocus rates TSE:7792 with a GF Score™ of 90/100 and a GF Value™ of 円1,539.80 (Fairly Valued). The stock has 2 warning signs investors should review. Among 857 Medical Devices & Instruments companies, Colan Totte Co ranks better than 97.43% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Colan Totte Co's annualizedNet Income for the quarter that ended in Mar. 2026 was 円1,372 Mil.
Colan Totte Co's average Total Assets over the quarter that ended in Mar. 2026 was 円7,094 Mil. Therefore, Colan Totte Co's annualized ROA % for the quarter that ended in Mar. 2026 was 19.34%.
The historical rank and industry rank for Colan Totte Co's ROA % or its related term are showing as below:
TSE:7792'
s ROA % Range Over the Past 10 Years
Min: 12.21 Med: 14.36 Max: 21.87
Current: 20.39
During the past 7 years, Colan Totte Co's highest ROA % was 21.87%. The lowest was 12.21%. And the median was 14.36%.
TSE:7792's ROA % is ranked better than 97.43% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.55
vs TSE:7792: 20.39
Colan Totte Co (TSE:7792) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Colan Totte Co ROA % Related Terms
Colan Totte Co ROA % Historical Data
* Premium members only.
The historical data trend for Colan Totte Co's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Colan Totte Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Colan Totte Co ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Colan Totte Co's ROA % distribution charts can be found below:
* The bar in red indicates where Colan Totte Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Colan Totte Co (TSE:7792) has a ROA % of 19.34% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Colan Totte Co and its competitors. This is 35% above median its historical median of 14.36. Over the past decade, Colan Totte Co's ROA % has ranged from 12.21 to 21.87. According to the industry distribution chart, Colan Totte Co ranks #22 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 2.6%.
Is Colan Totte Co's ROA % too high?
Colan Totte Co's current ROA % of 19.34% is 35% above median its 10-year median of 14.36. Over the past 10 years, this metric has ranged from a low of 12.21 to a high of 21.87. The Medical Devices & Instruments industry median ROA % is 0.55. Colan Totte Co's value of 19.34% is 3416.4% above this industry median. Based on the distribution chart, Colan Totte Co ranks #22 out of 857 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Colan Totte Co has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Colan Totte Co's ROA % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Colan Totte Co ranks #22 out of 857 companies for ROA %. This places Colan Totte Co in the top 3% of its industry — outperforming the majority of peers. The industry median ROA % is 0.55. Colan Totte Co's value of 19.34% is 3416.4% above this benchmark. Historically, Colan Totte Co's own ROA % has ranged from 12.21 to 21.87 over the past decade. While the company's 10-year median is 14.36 vs. the industry median of 0.55, Colan Totte Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.55, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Colan Totte Co's current ROA % of 19.34% is 3416.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Colan Totte Co and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Colan Totte Co's current ROA % is 19.34%, which is 35% above median its own 10-year median of 14.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Colan Totte Co stock overvalued right now?
Based on GuruFocus' analysis, Colan Totte Co (TSE:7792) is currently considered Fairly Valued. The stock's GF Value™ is 円1,539.80, compared to a current price of 円1,460.00 — trading 5.2% below its estimated fair value. The current ROA % is 19.34%, which is 35% above median its 10-year median of 14.36 and 3416.4% above the Medical Devices & Instruments industry median of 0.55. Colan Totte Co's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Colan Totte Co (TSE:7792), the current ROA % is 19.34% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Colan Totte Co (TSE:7792) Overvalued in 2026?
Based on GuruFocus' analysis, Colan Totte Co stock appears to be undervalued.
The current stock price of 円1,460.00 is trading 5.2% below its estimated GF Value™ of 円1,539.80.
GuruFocus considers Colan Totte Co to be Fairly Valued.
Key valuation signals for TSE:7792:
ROA %: 19.34% (35% above median its 10-year median of 14.36)
GF Value™: 円1,539.80 vs. price of 円1,460.00 (5.2% below fair value)
Industry Position: 3416.4% above the Medical Devices & Instruments median (#22 of 857)
No single metric tells the full story. See the TSE:7792 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Colan Totte Co Ltd is engaged in the manufacturing and sales of medical devices and health products. It divides its business into two segments: Colantotte Business is the brand that develops home magnetic therapy devices, which are the core of the company; and CSS Business is a service that connects people with their families, realizing contacting designated emergency contacts based on the desire to protect loved ones.
90GF Score
Get the complete analysis for TSE:7792
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7792 has been successfully added to your 
